We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Clinical trial results of a HER2/neu (E75) vaccine to prevent recurrence in high-risk breast cancer patients.
- Authors
Peoples, George E; Gurney, Jennifer M; Hueman, Matthew T; Woll, Mike M; Ryan, Gayle B; Storrer, Catherine E; Fisher, Christine; Shriver, Craig D; Ioannides, Constantin G; Ponniah, Sathibalan
- Abstract
E75 is an immunogenic peptide from the HER2/neu protein that is highly expressed in breast cancer. We are conducting a clinical trial of an E75 + granulocyte-macrophage colony-stimulating factor vaccine to assess safety, immunologic response, and the prevention of clinical recurrences in patients with disease-free, node-positive breast cancer (NPBC).
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Vol 23, Issue 30, p7536
- ISSN
0732-183X
- Publication type
Journal Article
- DOI
10.1200/JCO.2005.03.047